Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
6941- MF,  Ex,    The effects of pulsed electromagnetic field therapy on muscle strength and pain in patients with end-stage knee osteoarthritis: a randomized controlled trial
- Trial, Arthritis, NA
*Strength↑, *Pain↓, *eff↑, *Dose↝,
4349- MF,    Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial
- Trial, ostP, NA
*BMD↑, *Pain↓, *QoL↑, *toxicity↓, *Dose↝, *Inflam↓,
9299- MFrot,    Multifocal transcranial stimulation in chronic ischemic stroke: A phase 1/2a randomized trial
- Trial, Stroke, NA
*Dose↝, *motorD↑,
9269- MFrot,    Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial (OMX-EFS-01)
- Trial, GBM, NA
Dose↝, other↝,
8468- Mg,    The effect of long-term magnesium intake on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials
- Trial, Obesity, NA
*CRP↓,
8457- Mg,    The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial
- Trial, AD, NA
*Dose?, *cognitive↑, *memory↑, *RT↓, *Sleep↑, *toxicity↓, *rHR↓, *HRV↑,
8458- Mg,    Magnesium treatment increases gut microbiome synthesizing vitamin D and inhibiting colorectal cancer: results from a double-blind precision-based randomized placebo-controlled trial
- Trial, CRC, NA
*GutMicro↑, *VitD↑, Risk↓,
8462- Mg,    Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study
- Trial, Nor, NA
*BioAv↑,
8470- Mg,  Z,    The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial
- Trial, Nor, NA
*Dose?, *CRP↓, *PCO↓, *TAC↑, *IL1↓, *TNF-α↓,
8473- Mg,    Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial
- Trial, Nor, NA
*Dose↝, *hs-CRP↓,
8475- Mg,    Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep
- Trial, Nor, NA
*Dose↝, *Obesity↓, *CRP↓,
782- Mg,    Oral magnesium supplements for cancer treatment‐induced hypomagnesemia: Results from a pilot randomized trial
- Trial, Var, NA
*BioAv↑,
9086- MGF,    Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial
- Trial, Obesity, NA
*Dose↝, *TG/TAG↓, *FFA/NEFA↓, *IRes↓,
1781- MLT,    Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial
- Trial, Lung, NA
QoL↑, OS∅, selectivity↑,
7494- MLT,  Sul,    Medical and surgical treatments for tinnitus: the efficacy of combined treatment with sulodexide and melatonin
- Trial, Nor, NA
*Dose↝, *Tinn↓, *AntiThr↑,
8667- MLT,  Rad,    The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial
- Trial, CRC, NA
Dose↝, RBC↑,
8666- MLT,    Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial
- Trial, BC, NA
other↝, cognitive↑, memory↑, Verbal↑, neuroP↑, BDNF↓, TrkB↓, chemoP↑,
8665- MLT,  Rad,    Efficacy of Melatonin in Alleviating Radiotherapy-Induced Fatigue, Anxiety, and Depression in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
- Trial, BC, NA
Dose↝, fatigue↓, ANXi↓, antiD↑,
8664- MLT,  Rad,    Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial
- Trial, BC, NA
fatigue∅,
8691- MLT,    Melatonin effect on hypoxia inducible factor-1α and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial
- Trial, Oral, NA
Hif1a↓, Dose?, eff∅,
8677- MLT,    Evaluating the Cardioprotective Effects of Melatonin in Non-metastatic Breast Cancer Patients Receiving Doxorubicin Plus Cyclophosphamide: A Triple-Blind, Placebo-Controlled Randomized Controlled Trial
- Trial, BC, NA
cardioP↑, *other↑,
8674- MLT,    Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial
- Trial, Var, NA
Dose↝, eff∅,
8617- MO,    Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial
- Trial, AD, NA
*cognitive↑, *Mood↑, *Dose↝, *Dose?,
8614- MO,  RosA,    Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial
- Trial, AD, NA
*cognitive↑, *Dose↝,
8776- MSM,    Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial
- Trial, Arthritis, NA
Dose↝, eff↝, Inflam↓,
8781- MSM,    Methylsulfonylmethane for treatment of low back pain: A safety analysis of a randomized, controlled trial
- Trial, Nor, NA
*WBC∅, *PC∅, *Bil∅, *AST∅, *ALAT∅, *creat∅, *BP∅,
8769- MSM,    Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study
- Trial, Arthritis, NA
*Pain↓,
3851- MSM,    Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial
- Trial, Arthritis, NA
*Pain↓, *QoL↑,
8805- MT/VAE,  Chemo,    Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL)
- Trial, PC, NA
Dose?, QoL∅, Weight∅, CRP∅, ALB∅, Eos↑, eff∅, Synergy∅,
8802- MT/VAE,    Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects
- Trial, Nor, NA
*Dose↝, *hepatoP↑, *Half-Life↝, *ALAT↑, *AST↑, toxicity↝, Dose↝,
8800- MT/VAE,    Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
- Trial, Var, NA
Dose↝, QoL↑, DCR↑, Dose↝, other↝,
8945- mushLions,    The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study
- Trial, Nor, NA
*motorD↑, *NA↓, *Dose↑, *Dose↝,
8946- mushLions,    Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study
- Trial, AD, NA
*Dose?, *cognitive↑, *Calcium↑, *APOE4↑, *ALB↑, *HemoG↑, *BDNF↑, *ADC↓, *neuroP↑,
8947- mushLions,    Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial
- Trial, AD, NA
*Dose↝, *cognitive↑, *Ingr↝, *NGF↑,
8948- mushLions,    Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake
- Trial, AD, NA
*Ingr↝, *NGF↑, *Dose?, *antiD↑, *ANXi↓,
8949- mushLions,    Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?
- Trial, Obesity, NA
*antiD↑, *ANXi↓, *Sleep↑, *proBDNF↑, *Ingr↝, *Ingr↝, *Dose↝,
8969- mushLions,    Improvement of cognitive functions by oral intake of Hericium erinaceus
- Trial, AD, NA
*cognitive↑, *toxicity↓,
9303- MushMait,    A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
- Trial, BC, NA
Dose↝, *toxicity↓, Imm⇅, other↝, Dose↝, CD4+↑, IL2↑, IL10↑, TNF-α↑, IFN-γ↑, Imm↝,
9308- MushMait,    Maitake mushroom supplementation modulates upper respiratory symptoms and immune responses in healthy adults: a randomized, double-blind, placebo-controlled trial
- Trial, Nor, NA
*Dose?, *eff↑,
9309- MushMait,    Maitake Mushroom (Grifola frondosa) Enhances Cognitive Function in Healthy Older Japanese: A Randomized, Double-Blind, Placebo-Controlled Trial
- Trial, Nor, NA
*Dose↝, *cognitive↑, *NK cell↑, *Imm↑, *other↝,
2934- NAD,    The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
- Trial, Nor, NA
*Dose↑, *Strength↑,
5606- NaHCO3,    Effects of Alkalization Therapy on Chemotherapy Outcomes in Metastatic or Recurrent Pancreatic Cancer
- Trial, PC, NA
Dose↝, OS↑, Synergy↑,
5605- NaHCO3,    A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis
- Trial, HCC, NA
Synergy↑, Dose↝, other↓, OS↑, toxicity↓, AntiCan↓,
9215- Nast,    Clinical evaluation of the efficacy and safety of nasturtium herb and horseradish root versus placebo in the continuous prophylaxis of recurrent uncomplicated cystitis: a double-blind randomised clinical trial
- Trial, UTI, NA
*Inf↓, *Risk↓,
9216- Nast,    A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E2
- Trial, Nor, NA
*Dose↝, *PGE2∅,
5255- NCL,    Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial
- Trial, Nor, NA
BioAv↝, Dose↝, toxicity↓, BioAv↑, BioAv↝,
7708- NIV,  lpi,    Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
- Trial, CRC, NA
PFS↑,
7707- NIV,  lpi,    Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
- Trial, RCC, NA
OS↑, Dose↝,
6864- None,    Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
- Trial, AD, NA
*Risk↑, *cognitive↝,
7534- OLE,    An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis
- Trial, Arthritis, NA
*Pain↓, *Dose↝,

Showing Research Papers: 401 to 450 of 542
Prev Page 9 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 542

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ALAT↓, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 8,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   NOXA↑, 1,   Perforin↑, 1,   PUMA↑, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

ADCY4↑, 1,   p‑Akt↓, 1,   EGFR↓, 3,   IGF-2R↑, 1,   IGFR↓, 1,   PI3K↓, 1,   PTEN↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

HDAC↓, 4,   miR-106b↓, 1,   miR-19b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   Myc↓, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 24,   other∅, 3,   SD↑, 5,   SD↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

NEU1↑, 1,   TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↓, 1,   NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cellSen?, 1,   cycD1/CCND1↓, 2,   Ki-67↓, 6,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   JAG1↑, 1,   Ki-67↓, 6,   NOTCH3↑, 1,   Smo↓, 1,   TumCG↓, 9,   TumCP↓, 11,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 2,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   Snail↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 3,   TumCI↓, 3,   TumCMig↓, 3,   TumMeta↓, 2,   TumMeta↑, 1,   TumMeta∅, 1,   Twist↓, 1,   Vim↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 9,   angioG∅, 1,   E-sel↓, 1,   Endoglin↓, 1,   Hif1a↓, 2,   PGI2↓, 1,   VEGF↓, 4,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   MPT↑, 1,   TRPV1↑, 1,   ZO-1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC↓, 1,   ANXA1↓, 1,   CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 3,   CD8+↑, 5,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   Eos↑, 1,   FoxP3+↓, 1,   Gal-3?, 1,   Gal-3↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 2,   IL10↓, 1,   IL10↑, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 2,   IL1β∅, 1,   IL2↑, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 12,   Imm⇅, 1,   Imm↝, 1,   INF-γ↝, 1,   Inflam↓, 9,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 4,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 16,   T-Cell↑, 1,   TNF-α↓, 2,   TNF-α↑, 1,   TNF-α∅, 1,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↓, 1,   TrkB↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↓, 1,   2/16-OHE1↑, 1,   2/16-OHE1↝, 1,   ADRB2↓, 1,   AR↓, 3,   AR↝, 1,   DHT↓, 1,   ENL↑, 1,   EstroRS/ERS↑, 1,   PPARγ↓, 1,   SHBG↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 10,   BioAv↝, 10,   BioEnh↑, 1,   ChemoSen↑, 8,   ChemoSen∅, 1,   CYP1A2↑, 1,   CYP3A4⇅, 1,   Dose?, 13,   Dose↓, 3,   Dose↑, 7,   Dose↝, 152,   Dose∅, 4,   eff↓, 3,   eff↑, 40,   eff↝, 8,   eff∅, 12,   Half-Life↑, 1,   Half-Life↝, 6,   P-gp/ABCB1↓, 2,   RadioS↑, 5,   selectivity↑, 5,   Synergy?, 1,   Synergy↑, 10,   Synergy∅, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   ALB∅, 1,   AR↓, 3,   AR↝, 1,   AST↓, 1,   BG↓, 1,   Bil∅, 1,   BUN↓, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   CIT↓, 1,   creat↓, 1,   CRP↓, 3,   CRP∅, 1,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   HemoG↑, 1,   IL6↓, 4,   Myc↓, 1,   Mye↓, 1,   NLR↓, 1,   PC↑, 3,   Polyps↓, 1,   PSA↓, 16,   PSADT↓, 1,   PSADT↑, 3,   RBC↑, 4,   UFR↑, 1,   Verbal↑, 2,   VitD↑, 1,   WBC↑, 2,  

Functional Outcomes(tgid=23) ⓘ

AEs∅, 1,   AntiCan↓, 1,   AntiCan↑, 6,   antiD↑, 4,   antiNeop↑, 2,   AntiTum↑, 4,   AntiTum∅, 1,   ANXi↓, 4,   APG↓, 2,   cachexia↓, 1,   cardioP↑, 4,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 8,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   cognitive↑, 1,   cognitive∅, 1,   CR↑, 5,   DCR↑, 5,   DCR↝, 1,   fatigue↓, 5,   fatigue∅, 1,   hepatoP↓, 1,   hepatoP↑, 2,   LC↑, 1,   mal↓, 1,   memory↑, 2,   Mood↑, 1,   Mucositis↓, 5,   Nausea↓, 4,   Nausea∅, 2,   neuroP↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   ORR↑, 4,   ORR∅, 1,   OS?, 1,   OS↑, 55,   OS↝, 1,   OS∅, 11,   Pain↓, 9,   PFS?, 1,   PFS↑, 9,   PFS∅, 1,   QoL↑, 21,   QoL↝, 1,   QoL∅, 4,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   RFS↑, 1,   Risk↓, 14,   Risk↑, 2,   Risk↝, 2,   Risk∅, 6,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   Stress↓, 1,   toxicity↓, 29,   toxicity↑, 1,   toxicity↝, 26,   toxicity∅, 1,   TTP↑, 1,   TumVol↓, 4,   TumW↓, 1,   Vomit↓, 4,   Vomit∅, 2,   Weight↑, 6,   Weight∅, 2,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Diar↓, 1,   Diar⇅, 1,   GutMicro↑, 3,   Inf↓, 4,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 4,  
Total Targets: 317

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 12,   Bil↓, 2,   Bil∅, 1,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   Iron↑, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   PCO↓, 1,   ROS↓, 17,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 6,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12-HETE↓, 1,   5-HETE↓, 1,   ACLY↓, 1,   AcOH↑, 2,   adiP↑, 1,   ALAT↓, 6,   ALAT↑, 1,   ALAT∅, 2,   AMPK↑, 1,   Buty↑, 4,   CRM↑, 1,   DHA↑, 2,   Eic↓, 1,   FFA/NEFA↓, 1,   FFA/NEFA↝, 1,   glucose↓, 1,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDL↓, 11,   lipidLev↓, 1,   NH3↓, 1,   PA↑, 2,   SCFAs↑, 3,   SCFAs∅, 1,   SIRT1↑, 1,   Uridine↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

CK2↓, 1,   PI3K↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   DNMT3A↑, 1,   HDAC3↓, 1,   other?, 3,   other↓, 4,   other↑, 18,   other↝, 20,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 5,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VCAM-1↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   Eos↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 5,   IgA↑, 1,   IgE↓, 1,   IL1↓, 1,   IL10↓, 2,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 6,   IL4↑, 1,   IL4∅, 1,   IL6↓, 12,   IL8↓, 1,   Imm↑, 7,   Inflam↓, 26,   IP-10/CXCL-10↓, 1,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   MIP‑1α/CCL3?, 1,   NF-kB↓, 1,   NK cell↑, 5,   PGE2↓, 2,   PGE2∅, 1,   PSA↓, 1,   TNF-α↓, 9,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5-AR↓, 1,   5HT↑, 3,   Ach↑, 2,   AChE↓, 5,   BDNF↑, 8,   BDNF∅, 1,   proBDNF↑, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   NGF↑, 2,  

Protein Aggregation(tgid=19) ⓘ

APOE4↑, 1,   Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,   tau↓, 3,   p‑tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↑, 1,   cortisol↓, 1,   END↑, 1,   ENL↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5,   BioAv↑, 22,   BioAv↝, 14,   Dose?, 20,   Dose↓, 1,   Dose↑, 8,   Dose↝, 143,   eff↓, 2,   eff↑, 20,   eff↝, 8,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 20,   P450↓, 1,   Synergy↑, 6,  

Clinical Biomarkers(tgid=22) ⓘ

ADC↓, 1,   ALAT↓, 6,   ALAT↑, 1,   ALAT∅, 2,   ALB↑, 3,   ALP↓, 1,   AST↓, 4,   AST↑, 1,   AST∅, 2,   Bil↓, 2,   Bil∅, 1,   BloodF↑, 4,   BMD↑, 1,   BP↓, 12,   BP∅, 2,   Calcium↑, 1,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   creat∅, 1,   CRP↓, 5,   FEV1↑, 2,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 2,   HRV↑, 1,   hs-CRP↓, 2,   IL6↓, 12,   IRes↓, 1,   KeyT↝, 1,   LDH↓, 3,   NLR↓, 1,   PC∅, 1,   PEF↑, 1,   PSA↓, 1,   rHR↓, 1,   TC↓, 3,   TG/TAG↓, 3,   TMAO∅, 1,   UFR?, 1,   UFR↑, 1,   UR↓, 1,   Verbal↑, 2,   VitD↑, 1,   WBC∅, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 2,   AntiCan↑, 2,   antiD↑, 3,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 5,   BDI↓, 1,   BowelM↑, 1,   cardioP↑, 6,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 78,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 8,   IPSS↓, 1,   IPSS↝, 1,   Learn↑, 1,   memory↑, 26,   memory∅, 1,   Mood↑, 10,   motorD↑, 13,   MusCon↓, 1,   neuroP↑, 13,   NMSS↓, 1,   Obesity↓, 3,   OS↑, 1,   Pain↓, 12,   QoL?, 1,   QoL↑, 13,   RenoP↑, 3,   Risk↓, 6,   Risk↑, 2,   Risk↝, 1,   RT↓, 2,   Sleep↑, 12,   Strength↑, 4,   Stress↓, 6,   Tinn↓, 1,   toxicity↓, 40,   toxicity↑, 1,   toxicity↝, 4,   toxicity∅, 7,   UPDRS↓, 1,   UPDRSIII∅, 1,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 2,   AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,   GutMicro↑, 10,   GutMicro∅, 1,   Inf↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 8,  
Total Targets: 266

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page